Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Deep Venous Thrombosis

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Deep Venous Thrombosis

Sheikh M. Waheed et al.
Free Books & Documents

Excerpt

Deep vein thrombosis (DVT) is an obstructive disease with a hindering venous reflux mechanism. DVT usually involves the lower limb venous system, with clot formation originating in a deep calf vein and propagating proximally. See Image. Deep Vein Thrombosis. It is a common venous thromboembolic (VTE) disorder with an incidence of 1.6 per 1000 annually. The rate of particular site involvement depends on the anatomical location as follows, distal veins 40%, popliteal 16%, femoral 20%, common femoral 20%, and iliac veins 4%.

A deep-vein thrombosis (DVT) is a blood clot that forms within the deep veins, usually of the leg, but can occur in the arms and the mesenteric and cerebral veins. Deep-vein thrombosis is a common and important disease. It is part of the venous thromboembolism disorders, representing the third most common cause of death from cardiovascular disease after heart attacks and stroke. Even in patients who do not get pulmonary emboli, recurrent thrombosis and "post-thrombotic syndrome" are major causes of morbidity. Deep-vein thrombosis is a major medical problem accounting for most cases of pulmonary embolism. Only through early diagnosis and treatment can the morbidity be reduced.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Sheikh Waheed declares no relevant financial relationships with ineligible companies.

Disclosure: Pujitha Kudaravalli declares no relevant financial relationships with ineligible companies.

Disclosure: David Hotwagner declares no relevant financial relationships with ineligible companies.

References

    1. Huang Y, Ge H, Wang X, Zhang X. Association Between Blood Lipid Levels and Lower Extremity Deep Venous Thrombosis: A Population-Based Cohort Study. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221121282. - PMC - PubMed
    1. Chen R, Feng R, Jiang S, Chang G, Hu Z, Yao C, Jia B, Wang S, Wang S. Stent patency rates and prognostic factors of endovascular intervention for iliofemoral vein occlusion in post-thrombotic syndrome. BMC Surg. 2022 Jul 12;22(1):269. - PMC - PubMed
    1. Albricker ACL, Freire CMV, Santos SND, Alcantara ML, Saleh MH, Cantisano AL, Teodoro JAR, Porto CLL, Amaral SID, Veloso OCG, Petisco ACGP, Barros FS, Barros MVL, Souza AJ, Sobreira ML, Miranda RB, Moraes D, Verrastro CGY, Mançano AD, Lima RSL, Muglia VF, Matushita CS, Lopes RW, Coutinho AMN, Pianta DB, Santos AASMDD, Naves BL, Vieira MLC, Rochitte CE. Joint Guideline on Venous Thromboembolism - 2022. Arq Bras Cardiol. 2022 Apr;118(4):797-857. - PMC - PubMed
    1. Stubbs MJ, Mouyis M, Thomas M. Deep vein thrombosis. BMJ. 2018 Feb 22;360:k351. - PubMed
    1. Parker K, Thachil J. The use of direct oral anticoagulants in chronic kidney disease. Br J Haematol. 2018 Oct;183(2):170-184. - PubMed

Publication types

LinkOut - more resources